Selected article for: "disease severity and morbidity disease"
Author: Queisser, Kimberly A.; Mellema, Rebecca A.; Middleton, Elizabeth A.; Portier, Irina; Manne, Bhanu Kanth; Denorme, Frederik; Beswick, Ellen J.; Rondina, Matthew T.; Campbell, Robert A.; Petrey, Aaron C.
Title: COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction
  • Cord-id: kyc7x8ls
  • Document date: 2021_9_8
    • ID: kyc7x8ls
    Snippet: Vascular injury has emerged as a complication contributing to morbidity in coronavirus disease 2019 (COVID-19). The glycosaminoglycan hyaluronan (HA) is a major component of the glycocalyx, a protective layer of glycoconjugates that lines the vascular lumen and regulates key endothelial cell functions. During critical illness, as in the case of sepsis, enzymes degrade the glycocalyx, releasing fragments with pathologic activities into circulation and thereby exacerbating disease. Here, we analyz
    Document: Vascular injury has emerged as a complication contributing to morbidity in coronavirus disease 2019 (COVID-19). The glycosaminoglycan hyaluronan (HA) is a major component of the glycocalyx, a protective layer of glycoconjugates that lines the vascular lumen and regulates key endothelial cell functions. During critical illness, as in the case of sepsis, enzymes degrade the glycocalyx, releasing fragments with pathologic activities into circulation and thereby exacerbating disease. Here, we analyzed levels of circulating glycosaminoglycans in 46 patients with COVID-19 ranging from moderate to severe clinical severity and measured activities of corresponding degradative enzymes. This report provides evidence that the glycocalyx becomes significantly damaged in patients with COVID-19 and corresponds with severity of disease. Circulating HA fragments and hyaluronidase, 2 signatures of glycocalyx injury, strongly associate with sequential organ failure assessment scores and with increased inflammatory cytokine levels in patients with COVID-19. Pulmonary microvascular endothelial cells exposed to COVID-19 milieu show dysregulated HA biosynthesis and degradation, leading to production of pathological HA fragments that are released into circulation. Finally, we show that HA fragments present at high levels in COVID-19 patient plasma can directly induce endothelial barrier dysfunction in a ROCK- and CD44-dependent manner, indicating a role for HA in the vascular pathology of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acid citrate: 1
    • absence presence and activity level: 1
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and acute cardiac injury: 1, 2
    • absence presence and acute illness: 1, 2, 3, 4, 5, 6
    • absence presence and acute kidney injury: 1, 2, 3, 4, 5, 6, 7
    • accurate detection and acute ards respiratory distress syndrome: 1
    • accurate detection and acute illness: 1, 2
    • acid citrate and acute kidney injury: 1, 2
    • actin cytoskeleton and acute ards respiratory distress syndrome: 1
    • activate endothelium and acute ards respiratory distress syndrome: 1, 2
    • activity level and acute ards respiratory distress syndrome: 1
    • activity unit and acute ards respiratory distress syndrome: 1